Consolidated Statements of Profit or Loss
|
|
|
|
Year Ended December 31, |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
(in thousands of $ except for shares and EPS) |
|
Note |
|
2024 |
|
2023 |
|
2022 |
||||
Product net sales |
|
|
2,185,883 |
|
1,190,783 |
|
400,720 |
|||||
Collaboration revenue |
|
|
4,348 |
|
35,533 |
|
10,026 |
|||||
Other operating income |
|
|
61,808 |
|
42,278 |
|
34,520 |
|||||
Total operating income |
|
|
|
2,252,039 |
|
1,268,594 |
|
445,267 |
||||
|
|
|
|
|
|
|
|
|
||||
Cost of sales |
|
|
(227,289) |
|
(117,835) |
|
(29,431) |
|||||
Research and development expenses |
|
|
(983,423) |
|
(859,492) |
|
(663,366) |
|||||
Selling, general and administrative expenses |
|
|
(1,055,337) |
|
(711,905) |
|
(472,132) |
|||||
Loss from investment in a joint venture |
|
|
(7,644) |
|
(4,411) |
|
(677) |
|||||
Total operating expenses |
|
|
|
(2,273,693) |
|
(1,693,643) |
|
(1,165,607) |
||||
|
|
|
|
|
|
|
|
|
||||
Operating loss |
|
|
|
(21,654) |
|
(425,049) |
|
(720,341) |
||||
|
|
|
|
|
|
|
|
|
||||
Financial income |
|
|
157,509 |
|
107,386 |
|
27,665 |
|||||
Financial expense |
|
|
(2,464) |
|
(906) |
|
(3,906) |
|||||
Exchange (losses)/gains |
|
|
(48,211) |
|
14,073 |
|
(32,732) |
|||||
|
|
|
|
|
|
|
|
|
||||
Profit/(Loss) for the year before taxes |
|
|
|
85,180 |
|
(304,496) |
|
(729,314) |
||||
Income tax benefit |
|
|
747,860 |
|
9,443 |
|
19,720 |
|||||
Profit/(Loss) for the year |
|
|
|
833,040 |
|
(295,053) |
|
(709,594) |
||||
Profit/(Loss) for the year attributable to: |
|
|
|
|
|
|
|
|
||||
Owners of the parent |
|
|
|
833,040 |
|
(295,053) |
|
(709,594) |
||||
Weighted average number of shares outstanding |
|
|
59,855,585 |
|
57,169,253 |
|
54,381,371 |
|||||
Weighted average number of shares for purpose of diluted profit/(loss) per share |
|
|
65,177,815 |
|
57,169,253 |
|
54,381,371 |
|||||
Basic profit/(loss) per share (in $) |
|
|
13.92 |
|
(5.16) |
|
(13.05) |
|||||
Diluted profit/(loss) per share (in $) |
|
|
12.78 |
|
(5.16) |
|
(13.05) |
|||||
|